Notice of Funding Opportunity (NOFO) for Preclinical Testing of Drugs for Alzheimer's Disease
National Institutes of Health
Description
This grant supports testing drugs (either repurposed or new) combined with non-drug methods to treat Alzheimer's and related diseases. The aim is to achieve strong results in mice or cell models that can lead to repositioning these drugs and developing targeted combination therapies for treating and preventing these conditions.
This initiative will support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal of this NOFO is to establish robust proof of concept in mouse models or cell-based mo…
Source
Grant ID
PAR-25-374
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Aging
Key Dates
Opportunity Released
December 30, 2024
Eligibility
The following categories of applicants are invited to apply:
- Higher Education Institutions (Public/State-controlled)
- Higher Education Institutions (Private)
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations (Small Businesses)
- For-Profit Organizations (Other than Small Businesses)
- Eligible Agencies of the Federal Government
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Federal Governments
- Local Governments (general)
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- U.S. Territory or Possession
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
- Non-domestic (non-U.S.) components of U.S. Organizations)
Awards & Funding
Total Funding
$1M
Award Ceiling
$1M
Funding Amount
~$1M
Similar opportunities
- Notice of Funding Opportunity for Pre-clinical and Early Stage Clinical Development of Drug Candidates for Alzheimer's Disease
National Institutes of Health
- Notice of Funding Opportunity for Alzheimer's Disease and Related Dementias Clinical Trials
National Institutes of Health
- Notice of Funding Opportunity for Studies on Neuropsychiatric Symptoms in Alzheimer's Disease
National Institutes of Health
- Notice of Special Interest (NOSI): Novel Approaches to Characterizing and Diagnosing Alzheimer's Disease and Related Dementias
National Institutes of Health
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Department of Health and Human Services